Camrelizumab plus nab-paclitaxel in platinum-resistant patients with unresectable locally advanced or metastatic urothelial carcinoma: A multicentre, single-arm, phase II study

被引：1
|
作者：
Li, H. [1 ]
Chen, M. [1 ]
Xue, C. [2 ]
Li, L. [1 ]
Hu, A. [1 ]
Yang, W. [1 ]
Zheng, Z. [3 ]
Ni, M. [1 ]
Zhang, L. [1 ]
Zeng, Y. [1 ]
Peng, J. [1 ]
Yao, K. [4 ]
Zhou, F. [4 ]
Liu, Z. [4 ]
An, X. [1 ]
Shi, Y. [1 ]
机构：
[1] Sun Yat sen Univ, Med Oncol, Canc Ctr, Guangzhou, Peoples R China
[2] Sun Yat sen Univ, Med Oncol, Canc Ctr, Guangzhou, Guangdong, Peoples R China
[3] Sun Yat sen Univ, 3 Med Oncol, Affiliated Hosp 1, Guangzhou, Peoples R China
[4] Sun Yat sen Univ, Urol, Canc Ctr, Guangzhou, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.1822
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1744P
引用
收藏
页码：S1335 / S1335
页数：1
相关论文
共 50 条
  • [41] Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer.
    Yamada, Suguru
    Fujii, Tsutomu
    Takano, Nao
    Takami, Hideki
    Suenaga, Masaya
    Niwa, Yukiko
    Hayashi, Masamichi
    Iwata, Naoki
    Kanda, Mitsuro
    Kobayashi, Daisuke
    Tanaka, Chie
    Nakayama, Goro
    Sugimoto, Hiroyuki
    Koike, Masahiko
    Fujiwara, Michitaka
    Kodera, Yasuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [42] ROSELLA (GOG-3073, ENGOT-OV72/MITO): A PHASE 3 STUDY OF RELACORILANT plus NAB-PACLITAXEL VS. NAB-PACLITAXEL IN ADVANCED, PLATINUM-RESISTANT OVARIAN CANCER
    Lorusso, Domenica
    Bagameri, Andrea
    Bishop, Erin
    Chudecka-Glaz, Anita
    Devaux, Alix
    Gladieff, Laurence
    Gordinier, Mary E.
    Kim, Jae-Weon
    Korach, Jacob
    Mccollum, Michael E.
    Mileshkin, Linda
    Monk, Bradley J.
    Nicum, Shibani
    Nogueira-Rodrigues, Angelica
    Oaknin, Ana
    O'Malley, David
    Orlando, Mauro
    Dreiling, Lyndah
    Tudor, Iulia Cristina
    Olawaiye, Alexander B.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A411 - A412
  • [43] A phase Ib single-arm study of bintrafusp alfa for the treatment of pretreated, locally advanced/unresectable or metastatic urothelial cancer.
    Grivas, Petros
    Morales-Barrera, Rafael
    Sridhar, Srikala S.
    Loriot, Yohann
    Van der Heijden, Michiel Simon
    Galsky, Matt D.
    Baxter, Dawn
    Khaled, Ahmed Hussein
    Hug, Bruce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [44] Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
    Rosenberg, Jonathan E.
    Hoffman-Censits, Jean
    Powles, Tom
    van der Heijden, Michiel S.
    Balar, Arjun V.
    Necchi, Andrea
    Dawson, Nancy
    O'Donnell, Peter H.
    Balmanoukian, Ani
    Loriot, Yohann
    Srinivas, Sandy
    Retz, Margitta M.
    Grivas, Petros
    Joseph, Richard W.
    Galsky, Matthew D.
    Fleming, Mark T.
    Petrylak, Daniel P.
    Perez-Gracia, Jose Luis
    Burris, Howard A.
    Castellano, Daniel
    Canil, Christina
    Bellmunt, Joaquim
    Bajorin, Dean
    Nickles, Dorothee
    Bourgon, Richard
    Frampton, Garrett M.
    Cui, Na
    Mariathasan, Sanjeev
    Abidoye, Oyewale
    Fine, Gregg D.
    Dreicer, Robert
    LANCET, 2016, 387 (10031): : 1909 - 1920
  • [45] Relacorilant plus nab-paclitaxel in patients with recurrent, platinum-resistant ovarian cancer: Phase II subgroup analysis mirroring the patient population of an upcoming phase III study
    Colombo, N.
    Van Gorp, T.
    Matulonis, U. A.
    Oaknin, A.
    Grisham, R. N.
    Fleming, G.
    Olawaiye, A.
    Tudor, I. C.
    Pashova, H. I.
    Lorusso, D.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S793 - S793
  • [46] Neoadjuvant camrelizumab plus chemotherapy in patients with locally advanced cervical cancer (NACI): A prospective, single-arm, phase II trial
    Chen, J.
    Li, K.
    Han, Y.
    Shen, Y.
    Wang, Y.
    Song, K.
    Chen, X.
    Xia, B.
    Zou, D.
    Wang, Y.
    Ma, D.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S804 - S804
  • [47] Phase I Study of Carboplatin/Nab-Paclitaxel and Concurrent TRT in Elderly Patients with Unresectable Locally Advanced NSCLC
    Omori, S.
    Harada, H.
    Mori, K.
    Hisamatsu, Y.
    Tsuboguchi, Y.
    Yoshioka, H.
    Morinaga, R.
    Daga, H.
    Kurata, T.
    Takahashi, T.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S362 - S363
  • [48] A phase Ib/II study of rebastinib and paclitaxel in advanced/metastatic platinum-resistant ovarian cancer
    Hamilton, E. P.
    Goel, S.
    Arend, R.
    Chu, C.
    Richardson, D. L.
    Corr, B.
    John, V.
    Janku, F.
    Hays, J.
    Michenzie, M.
    Reichmann, W.
    Achour, H.
    Sherman, M. L.
    Ruiz-Soto, R.
    Mathews, C.
    ANNALS OF ONCOLOGY, 2021, 32 : S731 - S732
  • [49] A phase Ib/II study of rebastinib and paclitaxel in advanced or metastatic platinum-resistant ovarian cancer
    Hamilton, E. P.
    Goel, S.
    Arend, R.
    Chu, C.
    Richardson, D. L.
    Diamond, J. R.
    John, V.
    Janku, F.
    Matthews, C.
    JeBailey, L.
    Kuida, K.
    Achour, H.
    Ruiz-Soto, R.
    Hays, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S629 - S630
  • [50] Penpulimab combined with anlotinib and nab-paclitaxel plus gemcitabine (PAAG) as first-line treatment for advanced metastatic pancreatic cancer: A prospective, multicenter, single-arm, phase II study
    Du, J.
    Tong, F.
    Sha, H.
    Sun, Y.
    Zhu, Y.
    Qi, L.
    Li, X.
    Li, W.
    Yang, Y.
    Li, Z.
    Xu, C.
    Ni, J.
    Zhang, X.
    Zhu, C.
    Wang, X.
    Qian, X.
    Liu, B.
    ANNALS OF ONCOLOGY, 2023, 34 : S1535 - S1535
12345